

Founded in 2024, Biopeak operates in Health Tech industry. Initially, the company concentrated on developing at-home testing kits designed to offer convenient and accurate health insights for consumer...
Funding stage:
Undisclosed
Last funding:
28/01/2026
Total funding:
$6.20 Mn+
Revenue:
Investors
Employee count:
45
Last 90d
45
Last 90d
Web traffic:
21.64K
21.64K
Last 30d
Last 30d
Biopeak: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders9
- Latest Filing Date04 Dec 2025
- Funding Events7
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Biopeak
As of 05 December 2025, Biopeak's equity is held by 9 shareholders, with the top three being Prashanth Prakash, Rishi Pardal, and Nikhil Kamath.
Prashanth Prakash holds the largest stake in Biopeak at 37.9% as of 05 December 2025.
As of 05 December 2025, founders collectively hold 35.6% equity in Biopeak.
As of 05 December 2025, investors collectively hold 64.4% equity in Biopeak.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links